Hong Kong's top International Baccalaureate scorers credited AI and balanced study routines for their success, with students from Diocesan Boys' School, Victoria Shanghai Academy, and Po Leung Kuk Cho…
Wayve CEO Alex Kendall launched an $85 million employee tender offer at an $8.5 billion valuation, allowing staff to sell shares to existing and new investors. The move aims to retain talent amid rapi…
Researchers from the University of Cambridge and Nvidia introduced the Red Queen Gödel Machine (RQGM), a framework enabling AI agents and their evaluators to co-evolve, addressing stagnation in recurs…
Chinese chipmaker Basic Semiconductor is moving forward with an IPO in Hong Kong, betting on silicon carbide (SiC) semiconductors to address the power demands of AI-driven data centers. The company jo…
Researchers from the University of Cambridge and the University of Oxford have derived conditions under which data augmentation yields exact equivariance in Bayesian neural networks trained with varia…
Ångstrom AI (YC S24), in collaboration with the University of Cambridge and AstraZeneca, released CSP-MACE-Å, a machine learning model that achieves DFT accuracy for crystal structure prediction with …
Solve Intelligence, an AI startup growing 25% month-on-month, is hiring a founding design engineer to build UX for AI products. The role involves working directly with founders and AI researchers to d…
Russian families are using AI-generated videos and deepfakes to 'resurrect' loved ones killed in Ukraine, portraying soldiers as heroes while omitting the destruction of war. The practice has gained p…
The Tessera team released v1.1 of their geospatial embedding model, improving temporal stability and reducing noise in regions with sparse satellite observations. The update eliminates grid-like seams…
Scientists at the University of Cambridge and DIOSynVax have tested an AI-designed universal coronavirus vaccine in a Phase 1 trial involving 39 healthy volunteers, with results published in the Journ…
The University of Cambridge and biotech firm DIOSynVax Ltd announced on June 5 that a Phase I clinical trial of 39 healthy volunteers showed their AI-designed vaccine is safe, well-tolerated, and trig…
The University of Cambridge and its spin-out DIOSynVax (DVX) Ltd have completed the first-in-human Phase 1 trial of pEVAC-PS, an AI-designed "universal" Sarbeco coronavirus vaccine. The open-label, do…
A University of Cambridge team and spin-out DIOSynVax reported that a Phase 1 trial of an AI-designed "super-antigen" vaccine was safe and immunogenic in 39 healthy volunteers. The vaccine, whose acti…
Researchers at the University of Cambridge used artificial intelligence to develop an experimental pan-coronavirus vaccine that safely generated immune responses against multiple coronaviruses in a ph…
The University of Cambridge and spinout company DIOSynVax have successfully tested the first AI-designed universal coronavirus vaccine in humans, finding it safe and well-tolerated in a 39-volunteer t…
The University of Cambridge successfully tested a vaccine with an antigen designed entirely by artificial intelligence, marking the first time a computer-designed active component has been used in hum…
Researchers at the University of Cambridge have developed a "world-first" vaccine whose key component was designed entirely by artificial intelligence and tested in humans. The AI-engineered vaccine t…
Researchers from the University of Toronto, the University of Cambridge, and other institutions demonstrated a new AI-powered computer worm that autonomously generates tailored attack strategies for e…
Researchers at the University of Toronto, the Vector Institute, and the University of Cambridge have developed a proof-of-concept autonomous AI worm that uses a small, free large language model to ana…
British autonomous-vehicle software startup Wayve is launching a new research unit called Wayve Labs, led by chief scientist Jamie Shotton, to explore embodied intelligence systems beyond self-driving…